top of page

PathoVax LLC, is a start-up company that is based on foundational technology developed at Johns Hopkins University to advance RGVaxTM, the world’s first comprehensive HPV vaccine that aims to target all clinically relevant HPV. It is expected that such additional protection will eventually establish new standards in the $2B HPV market. PathoVax’s collaborative partnerships include well-known institutions such as the U.S. National Cancer Institute to push forward an academic phase 1 study

Board of Directors

  • White LinkedIn Icon
  • White Twitter Icon
  • White Google+ Icon

Dr Lai has more than 20 years’ of CMC operational experience in bio-pharmaceutical  and healthcare start-ups.
​Wen Bin obtained her Ph.D. from the University of Cambridge and received her MBA from the Singapore Management University, where she graduated as valedictorian.

Dr Kevin Koh, PhD

Dr Robert (‘”Bob”) Becker, PhD MBA is an experienced executive with a proven history in fostering partnerships with product development, cGMP manufacturing, clinical development and regulatory affairs 

Cynthia Poa
  • White LinkedIn Icon
  • White Twitter Icon
  • White Google+ Icon

Mr Jay Nadkarni joins PathoVax with 20+ years of experience in all aspects of new product commercialization and licensing; and has to his credit many successful licensing deals brought to fruition. He has a commendable track record in Innovation Management, Licensing, Business Development, and Technology Transfers for Biopharmaceuticals, Biologics, and Rx / OTC Pharmaceuticals all over the world with emphasis on Tier-1&2 Emerging Markets

Dr Alan Zhu
  • White LinkedIn Icon
  • White Twitter Icon
  • White Google+ Icon

Dr Wang trained in Papillomavirus VLPs at Johns Hopkins University. Prior to founding PathoVax, Joshua explored opportunities in innovation and venture creation at Flagship Ventures (now Flagship Pioneering).

Dr Joshua Wang
Anchor 1
Anchor 2

Scientific, Clinical Advisory Board, and Collaborators

Richard Roden, Ph.D
Co-director of Viral Oncology, Johns Hopkins School of medicine

Reinhard Kirnbauer, MD
Director of Viral Oncology,
Medical University Vienna
Warner Huh, M.D
Professor and Division Director of the Division of Gynecologic Oncology at the University of Alabama at Birmingham.
John Schiller, Ph.D
NIH Distinguished Investigator (Collaborator)
bottom of page